Health and Fitness Health and Fitness
Mon, September 3, 2012
[ Mon, Sep 03rd 2012 ] - Market Wire
Valeant Pharmaceuticals International, Inc. Agree .. ceutical Corporation For $44.00 Per Share In Cash
[ Mon, Sep 03rd 2012 ] - Market Wire
InterMune Reports New Analyses from the RECAP Study of Esbriet (pirfenidone) at ERS
[ Mon, Sep 03rd 2012 ] - Market Wire
AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference
Sun, September 2, 2012
[ Sun, Sep 02nd 2012 ] - Market Wire
Galapagos subsidiary BioFocus and Ono sign a drug .. discovery agreement in the Field of CNS Disorders
[ Sun, Sep 02nd 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Assisted Living Concepts, Inc.
Sat, September 1, 2012
[ Sat, Sep 01st 2012 ] - Market Wire
ADDING MULTIMEDIA Ironwood and Forest Announce FD .. clotide) for the Treatment of Irritable Bowel Syn
[ Sat, Sep 01st 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. 0 In Losses Investing In Assisted Living Concepts
[ Sat, Sep 01st 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. Investing In Assisted Living Concepts, Inc. To C
Fri, August 31, 2012
[ Fri, Aug 31st 2012 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Announces That .. Been Filed against Assisted Living Concepts Inc.
[ Fri, Aug 31st 2012 ] - Market Wire
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Assisted Living Concepts, Inc.
[ Fri, Aug 31st 2012 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against Assisted Living Concept
[ Fri, Aug 31st 2012 ] - Market Wire
Bronstein, Gewirtz amp;; Grossman, LLC Ann .. s Been Filed against Assisted Living Concepts Inc
[ Fri, Aug 31st 2012 ] - Market Wire
UnitedHealthcare Community Plan of Hawai&lsquo .. t Development of a Community Health Center in Wah
[ Fri, Aug 31st 2012 ] - Market Wire
Array BioPharma Announces Changes to Board of Directors
[ Fri, Aug 31st 2012 ] - Market Wire
American CareSource Holdings Announces Reverse Stock Split
[ Fri, Aug 31st 2012 ] - Market Wire
With Whooping Cough on the Rise, and a New School .. ’s Important for Kids to Get Vaccinated
[ Fri, Aug 31st 2012 ] - Market Wire
U.S. FDA Approves XTANDI(R) (enzalutamide) After .. With Metastatic Castration-Resistant Prostate Can
[ Fri, Aug 31st 2012 ] - Market Wire
First Freewheelin Pedal Bus Ride of the 2012 Democratic National Convention
[ Fri, Aug 31st 2012 ] - Market Wire
CMS awards $88.5M loan to Massachusetts for new health insurance model: Minuteman Health
[ Fri, Aug 31st 2012 ] - Market Wire
American Financial Group, Inc. Announces Completi .. dicare Supplement and Critical Illness Businesses
[ Fri, Aug 31st 2012 ] - Market Wire
Freewheelin Rolls on to the Democratic National Convention after a Great Run at the RNC in Tampa
[ Fri, Aug 31st 2012 ] - Market Wire
Acadia Healthcare to Present at the 2012 Baird Health Care Conference
[ Fri, Aug 31st 2012 ] - Market Wire
IsZo Capital amp;; Black Horse Write to Ta .. nformation Relating to Sun Pharmaceutical Going P
[ Fri, Aug 31st 2012 ] - Market Wire
Lawsuit Filed against Assisted Living Concepts, I .. ggering Deadline to Move for Lead Plaintiff, Says
[ Fri, Aug 31st 2012 ] - Market Wire
Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
[ Fri, Aug 31st 2012 ] - Market Wire
Cigna Completes Acquisition of Great American Supplemental Benefits Group
[ Fri, Aug 31st 2012 ] - Market Wire
Idera Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
[ Fri, Aug 31st 2012 ] - Market Wire
Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA
[ Fri, Aug 31st 2012 ] - Market Wire
Bacterin International to Present at Stifel Nicol .. s 2012 Healthcare Conference on September 6, 2012
[ Fri, Aug 31st 2012 ] - Market Wire
Sarepta Therapeutics to Present Company Overview .. ; Renshaw Annual Global Investment Conference

Sarepta Therapeutics to Present Company Overview at the 2012 Rodman &;; Renshaw Annual Global Investment Conference


Published on 2012-08-31 05:48:10 - Market Wire
  Print publication without navigation


August 31, 2012 08:30 ET

Sarepta Therapeutics to Present Company Overview at the 2012 Rodman & Renshaw Annual Global Investment Conference

Webcast Accessible via Sarepta Therapeutics Website

CAMBRIDGE, MA--(Marketwire - Aug 31, 2012) -  Sarepta Therapeutics (NASDAQ: [ SRPT ]), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the 2012 Rodman & Renshaw Annual Global Investment Conference in New York, NY on Monday, September 10, 2012 at 10:25 a.m. Eastern Time. Chris Garabedian, Sarepta's President and CEO, will be the presenter.

The presentation will be webcast live under the events section of Sarepta Therapeutics' website at [ www.sareptatherapeutics.com ] and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta Therapeutics -- formerly AVI BioPharma -- is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at [ www.sareptatherapeutics.com ].


Contributing Sources